Using conditional regression analysis, it was identified that individuals carrying the IL-17 rs763780 CC genotype demonstrated a marginally increased risk of developing gastric cancer when compared with the TT genotype in the codominant model, with an adjusted OR (95% CI) of 2.27 (1.51–3.45) (Table III). The gene discussed is IL17A; the disease is gastric cancer.